Evidence map›Paper›PMID 23117208›Full record

ArticleBone2013

Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices.

David J Gutekunst, Kirk E Smith, Paul K Commean, Kathryn L Bohnert, Fred W Prior, David R Sinacore

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Bone, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06684886 (Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06684886 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled60ConditionsDiabetic Foot Disease, Chronic Kidney Disease Due to Type 2 Diabetes MellitusArmsAnkle Brachial Index
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Candidate Imaging Marker for Early Detection of Charcot Neuroarthropathy.Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

David J GutekunstApplied Kinesiology Laboratory, Program in Physical Therapy, Washington University School of Medicine, 4444 Forest Park Blvd., Campus Box 8502, St. Louis, MO 63108, USA.
Kirk E Smith
Paul K Commean
Kathryn L Bohnert
Fred W Prior
David R Sinacore
Mallinckrodt (United States) · USWashington University in St. Louis · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI SILVA, MATTHEW J · 2009 to 2018
$5.7M
DOCTORAL TRAINING PROGRAM IN MOVEMENT SCIENCET32HD007434 · NICHD · WASHINGTON UNIVERSITY · PI Michael D Harris, Catherine Lang · 1993 to 2026
$4.2M
Biomarkers for Charcot Arthropathy in Diabetic PatientsR21DK079457 · NIDDK · WASHINGTON UNIVERSITY · PI PRIOR, FRED WILLIAM · 2007 to 2009
$825k
EX VIVO VALIDATION OF IMAGE-BASED BIOMARKER OF PEDAL BONE QUALITYR03HD068660 · NICHD · WASHINGTON UNIVERSITY · PI SINACORE, DAVID RUSSELL · 2012 to 2013
$148k
NIAMS NIH HHS P30 AR057235NIAMS NIH HHS T32 AR056950NICHD NIH HHS R03 HD068660NICHD NIH HHS T32 HD007434NICHD NIH HHS T32 HD007434-18NIDDK NIH HHS P30 DK020579NIDDK NIH HHS R21 DK079457
6 · The paper itself

Abstract

Charcot neuroarthropathy (CN), an inflammatory condition characterized by rapid and progressive destruction of pedal bones and joints, often leads to deformity and ulceration in individuals with diabetes mellitus (DM) and peripheral neuropathy (PN). Repetitive, unperceived joint trauma may trigger initial CN damage, causing a proinflammatory cascade that can result in osteolysis and contribute to subsequent neuropathic fracture. We aimed to characterize osteolytic changes related to development and progression of CN by measuring bone mineral density (BMD) and geometric strength indices using volumetric quantitative computed tomography. Twenty individuals with DM+PN were compared to twenty age-, sex-, and race-matched individuals with DM+PN and acute CN. We hypothesized that individuals with acute CN would have decreased BMD and decreased total area, cortical area, minimum section modulus, and cortical thickness in the diaphysis of the second and fifth metatarsals. Results showed BMD was lower in both involved and uninvolved feet of CN participants compared to DM+PN participants, with greater reductions in involved CN feet compared to uninvolved CN feet. There was a non-significant increase in total area and cortical area in the CN metatarsals, which helps explain the finding of similar minimum section modulus in DM+PN and CN subjects despite the CN group's significantly lower BMD. Larger cortical area and section modulus are typically considered signs of greater bone strength due to higher resistance to compressive and bending loads, respectively. In CN metatarsals, however, these findings may reflect periosteal woven bone apposition, i.e., a hypertrophic response to injury rather than increased fracture resistance. Future research using these techniques will aid further understanding of the inflammation-mediated bony changes associated with development and progression of CN and other diseases.

Indexed as

Bone DensityAgedFemaleHumansJoint DiseasesMaleMetatarsusMiddle AgedNervous System DiseasesRadiography

Identifiers

PMID23117208
PMCPMC3515650
OpenAlexW1997165448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.